EVT-0185

N/A

Report date: 2025/08/18 17:03:42
NME

Base Information

Drug NameEVT-0185
Drug Alias NameEVT0185
ClassificationSmall molecules
Mechanisms of ActionATP-citrate synthase inhibitorsAcetyl-coenzyme A synthetase, cytoplasmic inhibitorsAcetyl-CoA carboxylase 1 inhibitors +[4] 
TargetsATP-citrate synthaseAcetyl-coenzyme A synthetase, cytoplasmicAcetyl-CoA carboxylase 1 +[4] 
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEspervita Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEspervita Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A